Traverse 2024 Study. Lessons learned from traverse 2024. The traverse trial, a randomized controlled trial designed specifically to assess the cardiovascular safety of testosterone gel, has shown no increased.
In a video interview at the 24th annual fall scientific meeting of sexual medicine society of north america in san diego, california, mohit khera, md, mba, mph, highlights key findings and. Named the traverse study, results of the trial, which compared risk of cardiovascular events in people with hypogonadism using testosterone therapy versus.
